Last CNY16.87 CNY
Change Today +0.10 / 0.60%
Volume 10.8M
As of 3:05 AM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

zhejiang hisun pharmaceuti-a (600267) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/26/13 - CNY19.62
52 Week Low
05/19/14 - CNY13.53
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ZHEJIANG HISUN PHARMACEUTI-A (600267)

Related News

No related news articles were found.

zhejiang hisun pharmaceuti-a (600267) Related Businessweek News

No Related Businessweek News Found

zhejiang hisun pharmaceuti-a (600267) Details

Zhejiang Hisun Pharmaceutical Co. Ltd. provides various pharmaceutical products and services to patients and its business partners. The company provides antineoplastic, cardiovascular, anti-infection, endocrine control, anti-parasite, anti-tumor, anti-infective, and anti-immunosuppressive drugs, as well as animal remedies and muscle and skeletal system products. It also provides APIs and finished drugs, and medical information and product consulting services. The company markets and distributes its products under the HISUN brand in approximately 70 regions and countries. It has collaboration with Ambrx Inc. to develop and commercialize bispecifics for cancer. The company was founded in 1956 and is headquartered in Taizhou, China.

Founded in 1956

zhejiang hisun pharmaceuti-a (600267) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zhejiang hisun pharmaceuti-a (600267) Key Developments

Zhejiang Hisun Pharmaceutical Co., Ltd Announces Earnings Results for the First Half of 2014

Zhejiang Hisun Pharmaceutical Co., Ltd. announced earnings results for the first half of 2014. For the period, the company reported basic earnings per share of CNY 0.202 and weighted average return on net assets Of 3.411%.

Zhejiang Hisun Pharmaceutical Co., Ltd. to Report First Half, 2014 Results on Aug 26, 2014

Zhejiang Hisun Pharmaceutical Co., Ltd. announced that they will report first half, 2014 results on Aug 26, 2014

Zhejiang Hisun Pharmaceutical Co., Ltd. Proposes Amendments to the Company's Articles of Association

Zhejiang Hisun Pharmaceutical Co., Ltd. proposed to approve the amendments to the Company's articles of association, at the company's 2nd extraordinary general meeting of 2014 to be held on July 29, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600267:CH CNY16.87 CNY +0.10

600267 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600267.
View Industry Companies

Industry Analysis


Industry Average

Valuation 600267 Industry Range
Price/Earnings 46.0x
Price/Sales 1.6x
Price/Book 2.9x
Price/Cash Flow 46.0x
TEV/Sales 0.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHEJIANG HISUN PHARMACEUTI-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at